- B2C
- B2B
- Early StageStartup in initial stages
- Website
- Location
- Company size
- 11-50 people
- Total raised
- $11M
- Company type
- Biotech
- Markets
Hyasynth Bio careers
We make strains of yeast that produce cannabinoids.
The cannabinoids are a collection of over 100 different compounds, of which the two most popular are THC and CBD. They present an immense market opportunity that is at an intersection of nutritional, pharmaceutical and recreational use products. The industry is developing and growing rapidly as legislation and consumer perspective shifts, and as more research points towards the health benefits of cannabinoids.
To make these, and the other variations of cannabinoids, we've built our platform that is adaptable, efficient and scalable because it is based on engineered yeast. We grow yeast in fermenters, feeding just sugar and water, over the course of few days, after which we extract and purify the end product.
The cannabinoids are a collection of over 100 different compounds, of which the two most popular are THC and CBD. They present an immense market opportunity that is at an intersection of nutritional, pharmaceutical and recreational use products. The industry is developing and growing rapidly as legislation and consumer perspective shifts, and as more research points towards the health benefits of cannabinoids.
To make these, and the other variations of cannabinoids, we've built our platform that is adaptable, efficient and scalable because it is based on engineered yeast. We grow yeast in fermenters, feeding just sugar and water, over the course of few days, after which we extract and purify the end product.
Hyasynth Bio hasn't added any jobs yet
Get notified when Hyasynth Bio posts new jobs.
Zach Wiltshire
Co-founder @Hyasynth Bio ; @MassChallenge @IndieBio Grad ;
Engineering cannabinoid production in yeast
Alex Campbell
Co-founder @Hyasynth Bio ; @MassChallenge @IndieBio Grad ;
Engineering cannabinoid production in yeast
Shoham Mookerjee
Co-founder @Hyasynth Bio ; @MassChallenge @IndieBio Grad ;
Engineering cannabinoid production in yeast
Kevin Chen
CEO, Co-founder @Hyasynth Bio; @RebelBio Accelerator Graduation; Worked at @Synbiota; BSc @Queen's University;
Total raised
$11M
Funded over
4 rounds
Latest round
Series A (Sep 2019)
Quartzy • Houston • 2 weeks ago
Penumbra • Berlin • 2 weeks ago
Hopper • Seoul • 4 weeks ago
Lightspeed HQ • Canada • 4 weeks ago